Company intelligence / Profile preview

Biortica Agrimed

Ownership: Private
Development stage: Commercial

Overview

Australia’s largest B2B medicinal cannabis grower with a broad genetics library. The company supplies bulk quantities of shelf-ready product to customers who then irradiate/repackage for retail. Recent expansion includes introduction of new genetic varieties to the Australian market. Investment in Canadian genetics firm Apollo Green has enhanced their cultivar offerings. No clinical trial results reported; business model centers on cultivation/processing rather than drug development.

Therapeutic areas: PsychiatryNeurology
Modalities: Plant-derived therapySmall moleculeBiologic
Industry: Agriculture & AgTech

Drug pipeline

7 assets

Apex OG

Commercial

Indications: Medical cannabis

6 more assets in the full pipeline.

Request access →

Partnerships

Apollo Green Inc.

Beyond the preview

Go deeper on Biortica Agrimed.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Biortica Agrimed.

Explore the full profile